Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline consumer healthcare sdn. bhd. - pamabrom; paracetamol -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline consumer healthcare sdn. bhd. - paracetamol; caffeine -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline consumer healthcare sdn. bhd. - paracetamol -

Kenya - English - Pharmacy and Poisons Board

m/s sterling lab 104-105, midford house, midford gardens, m.g. - fexofenadine hydrochloride - film-coated tablet - 120 mg per tablet - fexofenadine

Kenya - English - Pharmacy and Poisons Board

m/s sterling lab 104-105, midford house, midford gardens, m.g. - fexofenadine hydrochloride - film-coated tablet - 180 mg per tablet - fexofenadine

Kenya - English - Pharmacy and Poisons Board

m/s sterling lab 105, midford house, midford gardens, m.g. road, - levocetirizine dihydrochloride & montelukast… - tablet - montelukast sodium : 10 mg levocetirizine… - montelukast combinations

United States - English - NLM (National Library of Medicine)

sterling-knight pharmaceuticals, llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 1 g - diclofenac sodium topical gel, 1% is indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands. • diclofenac sodium topical gel, 1% has not been evaluated for use on the spine, hip, or shoulder. diclofenac sodium topical gel is contraindicated in the following patients: • known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product [see warnings and precautions (5.7, 5.9)] • history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8)] • in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1)] pregnancy category c prior to 30 weeks gestation; category d starting 30 weeks gestation risk summary use of nsaids, including diclofenac sodium topical

United States - English - NLM (National Library of Medicine)

sterling-knight pharmaceuticals, llc - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - folic acid 1 mg

United States - English - NLM (National Library of Medicine)

sterling-knight pharmaceuticals, llc - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), pyridoxal 5-phosphate (unii: f06sge49m6) (pyridoxal 5-phosphate - unii:f06sge49m6), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), coenzyme q10, (2z)- (unii: u705vlf0vw) (coenzyme q10, (2z)- - unii:u705vlf0vw), alpha lipoic acid (unii: 73y7p0k73y) (.alpha.-lipoic acid - unii:73y7p0k73y), acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - folic acid 1 mg - methazel is indicated for the distinct nutritional requirements of patients in need of dietary supplementation as determined by a licensed medical practitioner. methazel should be administered under the supervision o f a licensed medical practitioner. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

sterling-knight pharmaceuticals,llc - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - folic acid 1 mg - this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.